|
Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting |
|
|
|
Titel: |
Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting |
Auteur: |
Tameris, Michele Rozot, Virginie Imbratta, Claire Geldenhuys, Hennie Mendelsohn, Simon C. Kany Luabeya, Angelique Kany Shenje, Justin Tredoux, Nicolette Fisher, Michelle Mulenga, Humphrey Bilek, Nicole Young, Carly Veldsman, Ashley Botes, Natasja Thole, Jelle Fritzell, Bernard Mukherjee, Rajat Jelsbak, Ingrid Murillo Rodriguez, Esteban Puentes, Eugenia Doce, Juana Marinova, Dessislava Gonzalo-Asensio, Jesús Aguilo, Nacho Martin, Carlos Scriba, Thomas J. Hatherill, Mark |
Verschenen in: |
EBioMedicine |
Paginering: |
Jaargang 114 () nr. C pagina's p. |
Jaar: |
2025 |
Inhoud: |
|
Uitgever: |
The Authors |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|